Intercellular adhesive molecule-1 (ICAM-1) in proliferative diabetic retinopathy

  • Andi A. Victor Department of Ophthalmology, Cipto Mangunkusumo General Hospital, Faculty of Medicine Universitas Indonesia
  • Tjahjono D. Gondhowiardjo Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia
  • Rahayuningsih Dharma
  • Sri W. A. Jusman
  • Vivi R. Yandri
  • Ressa Yuneta
  • Rizky E. P. Yuriza
Keywords: diabetic retinopathy, insulin, intercellular adhesion molecule-, type 2 diabetes mellitus


Purpose: To determine the level of intercellular adhesion molecule-1 (ICAM-1) in vitreous fluid of patients with proliferative diabetic retinopathy (PDR) and its affecting factors including HbA1c level, duration of diabetes mellitus (DM) and insulin usage.

Methods: A cross-sectional study was conducted in Cipto Mangunkusumo National General Central Hospital, Jakarta, Indonesia from June 2015 to August 2016. Thirty-three consecutive vitreous samples harvested from PDR patients underwent vitrectomy. The level of vitreous ICAM-1 was determined by enzyme-linked immunosorbent assay.

Results: Based on the glycemic status, vitreous ICAM-1 level in the uncontrolled glycemic group (21.61 ng/ml) was lower than controlled glycemic group (24.20 ng/ml). Patients with DM for more than 10 years had higher level of vitreous ICAM-1 (26.30 ng/ml). Vitreous ICAM-1 level in DM patients with insulin was higher than those without insulin (27.07 ng/ml vs. 24.17 ng/ml). There was no statistically significant difference between vitreous ICAM-1 levels among all groups (p > 0.05).

Conclusion: The concentration of vitreous ICAM-1 may not be influenced by glucose control and conventional insulin therapy.


Silva PAS, Cavallerano JD, Sun JK, et al. Proliferative diabetic retinopathy. In: Ryan SJ, et al. Retina. 5th ed. Philadelphia: Elsevier; 2013:1020-1048.

Flethcer EC, Chong NV. Retina. In: Riordan-Eva P, Whither JP (Eds) Vaughan & Asbury’s General Ophthalmology. 17th ed. London: McGraw Hill; 2007. chapter 10.

Fauci AS, Kasper DL, Longo DL, et al. Diabetes mellitus. In: Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson Jl, et al. Harrison’s Principles of Internal Medicine. 17th ed. USA: The McGraw-Hill; 2008. chapter 338.

Vitreoretinal Division, Department of Ophthalmology, Faculty of Medicine, University of Indonesia. Prevalence of diabetic retinopathy. Unpublished raw data; 2013.

Limb GA, Webster L, Soomro H, Janikoun S, Shiling J. Platelet expression of tumour necrosis factor-alpha (TNF-a), TNF receptors and intercellular adhesion molecule-1 (ICAM-1) in patients with proliferative diabetic retinopathy. Clin Exp Immunol. 1999;118:213-218.

Mroczek JA, Mlynczak JPO, Hojlo MM. Proliferative diabetic retinopathy—the influence of diabetes control on the activation of the intraocular molecule system. Diabetes Res Clin Pract. 2009;84:46-50. doi: 10.1016/j.diabres.2009.01.012

Zhang K, Ferreyra HA, Grob S, Bedell M, Zhang JJ. Diabetic retinopathy: genetics and etiologic mechanisms. In: Ryan SJ, et al. (Eds), Retina. 5th ed. Philadelphia: Elsevier; 2013:975-985.

Mroczek JA, Mlynczak JO. Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2-diabetes role of the inflammatory immune process in the pathogenesis of proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2008;246:1665-1670. DOI: 10.1007/s00417-008-0868-6

Ghonaim MM, El-Edel RH. Circulating cell adhesion molecules (sICAM-1 and sVCAM-1) and microangiopathy in diabetes mellitus. Ibnosina J Med BS. 2015;7(6):211-218.

Joussen AM, Poulaki V, Le ML, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18:1450-1452. doi: 10.1096/ij.03-1476fje

Yan Y, Zhu L, Hong L, Deng J, Song Y, Chen X. The impact of ranibizumab on the level of intercellular adhesion molecule type 1 in the vitreous of eyes with proliferative diabetic retinopathy. Acta Ophthalmol. 2016;94:358-364. DOI: 10.1111/aos.12806

El-Asrar AMA, Nawaz MI, Kangave D, et al. High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy. Mol Vis. 2011;17:1829-1838.

Ruszkowska-Ciastek B, Sokup A, Wernik T, et al. Effect of uncontrolled hyperglycemia on levels of adhesion molecules in patients with diabetes mellitus type 2. J Zhejiang Univ Sci B. 2015;16(5):355-361. doi: 10.1631/jzus.B1400218

Noda K, Nakao S, Zandi S, Sun D, Hayes KC, Hafezi-Moghadam A. Retinopathy in a novel model of metabolic syndrome and type 2 diabetes: new insight on the inflammatory paradigm. FASEB J. 2014;28(5):2038-2046. doi: 10.1096/fj.12-215715

Huang G, Gandhi JK, Zhong X, et al. TNF-a is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis. 2011 Mar 10;52(3):1336-44. doi: 10.1167/iovs.10-5768. Print 2011 Mar.

Nagineni CN, Kutty RK, Detrick B, Hooks JJ. Inflammatory cytokine induce intercellular adhesion molecule-1 (ICAM-1) mRNA synthesis and protein secretion by human retinal pigment epithelial cell cultures. Cytokine. 1996 Aug; 8(8):622-630.

Qaum T, Xu Q, Joussen AM, et al. VEGF-initiated blood retinal barrier breakdown in early diabetes. Retina. 2001 Sept; 42(10):2408-2413.

King GL, Buzney SM, Kahn CR, et al. Differential responsiveness to insulin of endothelial and support cells from micro- and macrovessels. J Clin Invest. 1983;71:974-979.

Jingi AM, Noubiap JJ, Essouma M, et al. Association of insulin treatment versus oral hypoglycemic agents with diabetic retinopathy and its severity in type 2 diabetes patients in Cameroon, sub-Saharan Africa. Ann Transl Med. 2016 Oct;4(20):395. DOI: 10.21037/atm.2016.08.42

Hirata F, Yoshida M, Niwa Y, et al. Insulin enhances leukocyte endothelial cell adhesion in the retinal microcirculation through surface expression of intercellular adhesion molecule-1. Microvasc Res. 2005;69:135-141. doi: 10.1016/j.mvr.2005.03.002

How to Cite
Victor, A., Gondhowiardjo, T., Dharma, R., Jusman, S., Yandri, V., Yuneta, R., & Yuriza, R. (2020). Intercellular adhesive molecule-1 (ICAM-1) in proliferative diabetic retinopathy. Asian Journal of Ophthalmology, 17(1), 120-127.